Heart failure and COVID-19: synergism of two inflammatory conditions?

Area of Science:

• Geriatrics
• Infectious Diseases
• Cardiology

Background:

• Heart failure (HF) in older adults presents significant challenges.
• COVID-19 infection introduces complex comorbidities, particularly in elderly patients.
• The intersection of HF and COVID-19 exacerbates pathological outcomes.

Purpose of the Study:

• To explore the interplay of shared risk factors between COVID-19 and HF in the elderly.
• To understand the clinical difficulties in managing patients with both conditions.
• To provide practice recommendations for primary care management of HF during the COVID-19 pandemic.

Main Methods:

• Literature review and analysis of existing evidence and guidelines.
• Exploration of common pathological pathways including inflammation and coagulopathy.
• Assessment of challenges related to polypharmacy and nutritional status.

Main Results:

• COVID-19 and HF share risk factors, intensifying adverse health outcomes.
• Common inflammatory pathology and coagulopathy are significant concerns.
• Polypharmacy and nutritional challenges complicate patient care and increase arrhythmia risk.

Conclusions:

• The co-existence of COVID-19 and HF in older adults presents a grave clinical scenario.
• Effective management requires addressing shared risk factors, polypharmacy, and nutritional deficits.
• Evidence-based guidelines are crucial for optimizing primary care for these patients.